|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Biochemistry, 2Institute of Cardiovascular Research, Chonbuk National University Medical School, Jeonju, Republic of Korea
Submitted 20 November 2007 ; accepted in final form 28 April 2008
ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca2+-mobilizing second messenger, cADP-ribose (cADPR), from NAD+. In this study, we investigated the molecular basis of ADPR-cyclase activation in the ANG II signaling pathway and cellular responses in adult rat cardiomyocytes. The results showed that ANG II generated biphasic intracellular Ca2+ concentration increases that include a rapid transient Ca2+ elevation via inositol trisphosphate (IP3) receptor and sustained Ca2+ rise via the activation of L-type Ca2+ channel and opening of ryanodine receptor. ANG II-induced sustained Ca2+ rise was blocked by a cADPR antagonistic analog, 8-bromo-cADPR, indicating that sustained Ca2+ rise is mediated by cADPR. Supporting the notion, ADPR-cyclase activity and cADPR production by ANG II were increased in a time-dependent manner. Application of pharmacological inhibitors and immunological analyses revealed that cADPR formation was activated by sequential activation of Src, phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (Akt), phospholipase C (PLC)-
1, and IP3-mediated Ca2+ signal. Inhibitors of these signaling molecules not only completely abolished the ANG II-induced Ca2+ signals but also inhibited cADPR formation. Application of the cADPR antagonist and inhibitors of upstream signaling molecules of ADPR-cyclase inhibited ANG II-stimulated hypertrophic responses, which include nuclear translocation of Ca2+/calcineurin-dependent nuclear factor of activated T cells 3, protein expression of transforming growth factor-β1, and incorporation of [3H]leucine in cardiomyocytes. Taken together, these findings suggest that activation of ADPR-cyclase by ANG II entails a novel signaling pathway involving sequential activation of Src, PI 3-kinase/Akt, and PLC-
1/IP3 and that the activation of ADPR-cyclase can lead to cardiac hypertrophy.
angiotensin II; calcium ion, adenosine 5'-triphosphate-ribosyl cyclase; cardiomyocytes
This article has been cited by other articles:
![]() |
R. Gul, J.-H. Park, S.-Y. Kim, K. Y. Jang, J.-K. Chae, J.-K. Ko, and U.-H. Kim Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy Cardiovasc Res, September 11, 2008; (2008) cvn232v2. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |